background
diagnosi
communityacquir
pneumonia
cap
caus
mycoplasma
pneumonia
mp
children
hamper
difficulti
obtain
convalesc
serum
time
constraint
studi
two
diagnost
assay
target
respect
mpantibodi
mpdna
retrospect
investig
method
total
children
clinic
diagnos
cap
confirm
chest
xray
march
februari
children
hospit
hebei
provinc
china
sera
sputum
sampl
collect
h
admiss
mpantibodi
examin
passiv
particl
agglutin
assay
fourfold
greater
increas
antibodi
titer
pair
sera
titer
singl
serum
set
serolog
posit
mpdna
sputum
sampl
test
multiplexpcr
method
name
gexp
assay
multiplex
pcr
combin
autom
capillari
electrophoresi
order
elimin
fals
posit
result
caus
asymptomat
carriag
infect
pneumonia
inconsist
sampl
test
realtim
isotherm
transcriptionmedi
rna
amplif
assay
sat
interr
agreement
test
perform
cap
patient
highest
kappa
valu
schoolag
children
case
show
inconsist
result
determin
gexp
serolog
assay
gexp
serolog
sampl
randomli
chosen
gexp
serolog
sampl
test
sat
assay
diagnosi
agreement
observ
sat
gexp
assay
serolog
assay
addit
patient
detect
serolog
multiplexpcr
significantli
younger
method
posit
year
vs
year
p
viralmp
coinfect
account
common
winter
spring
p
infantil
group
p
compar
pure
mp
posit
one
children
cap
case
mp
laboratori
diagnosi
inconsist
serolog
multiplexpcr
assay
verifi
sat
assay
gexp
show
sensit
reliabl
perform
compar
serolog
assay
furthermor
employ
multiplexpcr
could
provid
inform
associ
pathogen
clinic
assess
cap
mycoplasma
pneumonia
mp
lead
caus
communityacquir
pneumonia
cap
especi
pediatr
popul
golden
diagnost
criteria
pneumonia
infect
consid
seroconvers
rise
igg
titer
antibodi
result
suscept
children
age
immun
statu
especi
face
difficulti
obtain
convalesc
serum
pediatr
hospit
due
advantag
pcr
sensit
specif
earli
detect
larg
bodi
literatur
publish
use
pcr
detect
mpdna
rna
includ
convent
nest
realtim
multiplex
isotherm
amplif
pcr
among
multiplexpcr
accept
practic
diagnosi
method
pneumonia
cap
exist
clinic
similar
result
mp
agent
common
appear
viral
coinfect
thu
recent
studi
pneumonia
ad
previous
use
pathogen
panel
includ
typessubtyp
virus
meanwhil
sever
group
also
design
multiplexpcr
earli
detect
pneumonia
infect
far
direct
comparison
multiplexpcr
serolog
test
larger
pediatr
clinic
sampl
rare
report
besid
pneumonia
rna
detect
realtim
isotherm
transcriptionmedi
rna
amplif
assay
mpsat
target
specif
invent
investig
could
elimin
fals
posit
case
result
previou
infect
nonpathogen
carrier
state
studi
sputum
sampl
obtain
analyz
commerci
multiplexpcr
kit
name
gexp
multiplex
amplif
assay
typessubtyp
pathogen
includ
pneumonia
commonli
detect
patient
cap
passiv
particl
agglutin
pa
assay
use
examin
patient
mpantibodi
serum
specimen
comparison
two
assay
conduct
mpsat
assay
use
test
inconsist
sampl
possibl
factor
may
contribut
disagr
result
also
analyz
protocol
use
retrospect
studi
review
approv
institut
review
board
children
hospit
hebei
provinc
written
inform
consent
obtain
patient
parent
prior
enrol
select
specimen
period
cover
four
season
base
cap
diagnosi
manag
guidelin
total
otherwis
healthi
children
age
year
median
year
confirm
chest
xray
final
enrol
respect
receiv
mpantibodi
mpdna
test
within
h
admiss
patient
congenit
heart
lung
diseas
immunosuppress
receiv
immunosuppress
therapi
admit
hospit
longer
day
within
last
day
exclud
detect
mpantibodi
passiv
particl
agglutin
assay
pair
serum
sampl
taken
present
pneumonia
least
day
first
collect
serum
serum
obtain
ml
whole
blood
separ
gel
tube
determin
mpspecif
antibodi
perform
use
commerci
avail
microparticl
agglutin
test
serodiamycoii
kit
fujirebio
tokyo
japan
accord
manufactur
instruct
antibodi
titer
measur
rang
dilut
criteria
diagnosi
defin
rise
pair
sera
pneumonia
antibodi
singl
serum
titer
patient
ask
cough
expector
sputum
collect
child
young
cough
steril
neg
pressur
suction
cathet
appli
obtain
oropharyng
suction
op
transport
tube
contain
ml
dmem
medium
heatinactiv
fetal
calf
serum
iuml
penicillin
streptomycin
gibco
beij
china
sampl
store
day
pathogen
nucleic
acid
extract
total
nucleic
acid
dna
rna
extract
sputum
sampl
elut
nucleasefre
water
easypur
viral
dnarna
kit
qsjbio
beij
china
accord
manufactur
instruct
afterward
extract
nucleic
acid
analyz
gexpbas
assay
remain
sputum
sampl
ad
equal
volum
preserv
solut
store
freezer
detect
mpdna
autom
genomelab
gexp
genet
analysi
system
gexp
assay
genomelab
gexp
genet
analysi
system
perform
specimen
follow
differ
respiratori
pathogen
influenza
flu
influenza
b
flu
b
influenza
influenza
human
parainfluenza
viru
hpiv
respiratori
syncyti
viru
rsv
rhinoviru
hrv
adenoviru
adv
human
metapneumoviru
hmpv
human
bocaviru
hbov
human
coronaviru
hcov
chlamydia
ch
mycoplasma
pneumonia
mp
use
respiratori
pathogen
multiplex
kit
pcrcapillari
electrophoresi
fragment
analysi
health
gene
tech
ningbo
china
revers
transcript
rt
pcr
perform
previous
describ
wang
et
al
analysi
perform
autom
manner
follow
establish
protocol
data
compil
gexp
system
softwar
provid
beckman
coulter
frozen
sputum
specimen
thaw
day
assay
perform
rna
extract
perform
magx
autom
platform
rendu
biotech
shanghai
china
target
could
enrich
purifi
magnet
particl
final
rna
elut
nucleasefre
water
neg
posit
control
also
introduc
next
mpsat
procedur
reaction
perform
follow
incub
min
min
sat
enzym
ad
reaction
mpsat
complet
realtim
thermocycl
veriti
thermal
cycler
appli
biosystem
china
follow
step
min
repeat
cycl
fluoresc
light
channel
set
fam
sampl
channel
hex
intern
control
channel
amplifi
product
assess
use
sat
analysi
system
rendu
biotech
realtim
pcr
ct
defin
posit
pearson
linearbylinear
associ
chisquar
test
use
compar
sex
admiss
season
age
subgroup
kruskalw
test
use
compar
mean
age
onset
ill
spss
statist
packag
spss
inc
chicago
usa
softwar
use
statist
analysi
p
consid
statist
signific
sputum
serum
specimen
collect
hospit
children
test
gexp
assay
pa
assay
respect
total
sampl
posit
sampl
neg
base
two
method
inconsist
sampl
account
kappa
valu
ordinari
p
highest
kappa
valu
observ
schoolag
children
group
tabl
better
understand
discord
sampl
term
fals
posit
fals
neg
rate
serolog
introduc
premis
use
assum
result
multiplexpcr
gold
standard
sampl
test
serolog
multiplexpcr
present
fals
posit
serolog
multiplexpcr
present
fals
neg
found
fals
posit
fals
neg
rate
serolog
significantli
p
associ
age
tabl
fals
posit
sampl
took
proport
age
year
age
year
similarli
fals
neg
sampl
account
age
year
old
respect
total
patient
posit
serolog
result
pair
sera
collect
patient
interestingli
pair
sera
sampl
good
agreement
multiplexpcr
result
case
four
fold
increas
titer
correspond
multiplexpcr
posit
addit
children
pneumonia
detect
serolog
multiplexpcr
alon
significantli
younger
detect
method
z
p
signific
differ
observ
admiss
season
p
sex
p
tabl
total
case
inconsist
result
reanalyz
mpsat
assay
randomli
chose
sampl
case
determin
serolog
mxpcr
togeth
whole
serolog
mxpcr
case
among
sputum
sampl
redo
mpsat
assay
found
diagnosi
agreement
sat
gexp
assay
total
serolog
mxpcr
case
determin
sat
posit
whole
serolog
mxpcr
case
test
sat
neg
addit
file
tabl
ninetyseven
patient
caus
pathogen
besid
pneumonia
among
patient
hrv
detect
follow
hpiv
flub
adv
rsv
hcov
hbov
hmpv
tabl
comparison
two
patient
group
infect
pneumonia
mix
infect
virus
signific
discrep
exist
differ
season
age
subgroup
sex
group
tabl
season
distribut
analysi
reveal
patient
infect
pneumonia
mix
infect
patient
summer
autumn
spring
winter
mix
infect
patient
show
predomin
p
interestingli
posit
detect
rate
schoolag
children
highest
pneumonia
group
lowest
mix
infect
group
p
nucleic
acid
amplif
techniqu
naat
target
toward
dna
rna
increasingli
explor
identif
pathogen
includ
pneumonia
infecti
respiratori
diseas
far
studi
describ
applic
naat
pathogen
detect
children
cap
determin
well
comparison
laboratori
diagnosi
method
pneumonia
infect
childhood
cap
larger
clinic
databas
report
present
studi
appli
multiplexpcr
name
gexp
assay
detect
type
pathogen
includ
pneumonia
sputum
sampl
hospit
cap
children
meanwhil
serum
specimen
also
collect
test
antibodi
pneumonia
comparison
serolog
gexp
assay
patient
case
diagnos
either
posit
neg
base
method
randomli
chose
sampl
sampl
test
inconsist
serolog
gexp
assay
redo
mpsat
found
diagnosi
agreement
sat
gexp
assay
serolog
test
analysi
reveal
children
pneumonia
examin
posit
gexp
serolog
significantli
younger
method
posit
patient
virusmp
coinfect
observ
infantil
patient
season
distribut
analysi
reveal
virusmp
coinfect
predomin
spring
winter
mponli
infect
frequent
identifi
summer
autumn
report
thu
far
describ
comparison
serolog
monopcr
assay
pneumonia
detect
pediatr
cap
patient
use
pair
sera
sampl
three
independ
research
group
observ
excel
diagnosi
agreement
method
discrep
mainli
attribut
proport
pair
sera
result
patient
provid
second
sera
specimen
good
concord
could
observ
pair
sera
multiplexpcr
hand
compar
monopcr
serolog
assay
kim
propos
singl
titer
consid
indic
acut
pneumonia
infect
clinic
presumpt
diagnosi
could
made
singl
acutephas
serum
titer
therefor
interpret
multiplexpcr
posit
sampl
truli
indic
mp
infect
high
fals
posit
rate
serolog
test
may
caus
proport
pair
sera
criteria
diagnosi
besid
serolog
fals
posit
rate
probabl
due
two
aspect
firstli
serolog
assay
claim
detect
mpigm
igg
posit
serolog
result
may
caus
earlier
current
mp
infect
still
detect
blood
altern
current
infect
truli
exist
amount
organ
detect
limit
multiplexpcr
report
diagnost
accuraci
pcr
may
decreas
day
onset
diseas
contrast
serolog
especi
patient
receiv
week
durat
antibiot
treatment
besid
monopcr
studi
review
loen
et
al
sever
group
appli
multiplexpcr
detect
pneumonia
infect
comparison
assay
set
cultur
andor
monopcr
suitabl
accuraci
valid
methodolog
establish
process
rather
obtain
clinic
diagnost
signific
addit
due
high
viral
coinfect
preval
report
chen
essenti
recommend
use
multiplexpcr
assay
provid
pathogen
inform
importantli
mp
igmposit
children
neg
pcr
result
report
associ
coinfect
pathogen
result
also
demonstr
youngest
children
group
exhibit
highest
serolog
multiplexpcr
rate
highest
coinfect
rate
young
children
sinc
serolog
posit
case
may
result
pathogen
infect
multiplexpcr
use
rectifi
sort
fals
posit
case
determin
serolog
furthermor
number
studi
demonstr
weak
defer
antibodi
respons
pneumonia
young
children
suggest
possibl
reason
lead
highest
serolog
multiplexpcr
rate
observ
youngest
patient
group
studi
conclus
owe
high
coinfect
rate
weak
antibodi
respons
young
children
mp
infect
need
monitor
serolog
assay
combin
serolog
multiplexpcr
allow
decreas
fals
posit
fals
neg
rate
serolog
assay
present
studi
inconsist
result
observ
took
proport
besid
multiplexpcr
serolog
sampl
mention
remain
discord
sampl
multiplexpcr
serolog
previou
work
shown
colon
pneumonia
may
caus
fals
posit
result
rule
possibl
fals
posit
result
multiplexpcr
target
mpdna
caus
colon
sat
assay
target
mprna
appli
found
overwhelm
major
multiplexpcr
serolog
sputum
specimen
prove
sat
posit
contrast
randomli
select
multiplexpcr
serolog
sputum
specimen
observ
sat
neg
data
suggest
multiplexpcr
assay
would
reliabl
serolog
assay
exhibit
opposit
result
howev
felt
verif
experi
larger
sampl
size
use
futur
work
anoth
limit
work
highli
special
equip
need
name
autom
nucleic
acid
extract
system
could
carri
sampl
one
time
h
mani
primari
hospit
clinic
laboratori
equip
manual
work
would
greatli
increas
turnaround
time
addit
file
